Kevin Kinsella
-
HHS secretary directs wide‑ranging federal vaccine review
Multi-agency vaccine safety review prompts pushback from former CDC officials and researchers for revisiting issues already extensively studied.
-
Health Canada seeks input on new drug review process
Proposed framework would allow Canadian regulator to use drug approval decisions from foreign agencies to speed up approvals in Canada.
-
Optum Rx launches ‘transparent,’ fee‑based pharmacy benefit model
The PBM’s announcement model comes amid growing pressure on the nation’s largest pharmacy benefit managers to abandon opaque pricing structures and comply with expanding federal and state transparency requirements.
-
Medicare to offer $50 monthly access to GLP‑1 drugs under new CMS demonstration
Part D enrollees will gain $50 monthly access to select GLP-1 medications through a new CMS demonstration program – but at what price?
-
FDA Commissioner Marty Makary out following policy dispute
Makary stepped down amid a widening rift over tobacco regulation and a series of contentious decisions that reshaped the FDA’s internal politics.
-
Millions of documented and undocumented Latinos to lose health coverage
New report finds US is facing a historic drop in health coverage as major program cuts take effect.
-
Pharma congress tackles using AI in pharmaceutical compliance practice
At PCC 2026, pharma attendees heard that companies need to balance automation with human oversight while navigating evolving expectations around transparency, risk, and ethical implementation.
-
CMS announces national effort to modernize prior authorization
Shift to all-electronic PA system could save billions, ease provider burden, and create interoperable healthcare ecosystem for the 21st century, says CMS Administrator Oz.